NASDAQ:IPHA
Innate Pharma S.A.
- Stock
Last Close
1.93
02/05 08:31
Market Cap
163.52M
Beta: 0.32
Volume Today
18.96K
Avg: 17.77K
PE Ratio
−1.87
PFCF: −9.30
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Dec '24 | Jun '25 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 6.66M - | 9.32M 40.01% | 5.70M 38.88% | 2.79M 50.96% | 22.79M 716.13% | 41.27M 81.06% | 6.04M 85.36% | 8.31M 37.52% | 20.10M 141.89% | 35.34M 75.85% | 10.72M 69.67% | 16.56M 54.43% | 6.17M 62.72% | 6.17M 0% | 4.33M 29.87% | 4.86M 12.27% | |
cost of revenue | 10.60M - | 10.60M 0% | 12.90M 21.63% | 12.90M 0% | 12.48M 3.26% | 12.48M 0% | 13.35M 7.02% | 13.35M 0% | 15.73M 17.77% | 15.73M 0% | 12.28M 21.89% | 14.54M - | 14.54M 0% | 4.33M 70.22% | 20.52M 374.01% | ||
gross profit | -3.95M - | -1.28M 67.45% | -7.20M 460.51% | -10.11M 40.30% | 10.32M 202.09% | 28.79M 179.10% | -7.31M 125.39% | -5.04M 31.01% | 4.37M 186.68% | 19.62M 348.66% | -1.56M 107.97% | 16.56M 1,159.31% | -8.37M 150.53% | -8.37M 0% | -15.66M - | ||
selling and marketing expenses | 57.50K - | 57.50K 0% | 139K 141.74% | 139K 0% | 187.50K 34.89% | 187.50K 0% | 77.50K 58.67% | 77.50K 0% | 71K 8.39% | 71K 0% | 87K 22.54% | 82K - | 82K 0% | 156K - | |||
general and administrative expenses | 6.26M - | 6.26M 0% | 6.30M 0.60% | 6.30M 0% | 5.88M 6.65% | 5.88M 0% | 5.07M 13.80% | 5.07M 0% | 4.50M 11.23% | 4.50M 0% | 4.49M 0.36% | 4.71M - | 4.71M 0% | 9.61M - | |||
selling general and administrative expenses | 6.32M - | 13.38M 111.74% | 6.44M 51.88% | 5.51M 14.51% | 6.07M 10.24% | 11.37M 87.35% | 5.15M 54.73% | 9.57M 85.86% | 4.57M 52.22% | 8.54M 86.85% | 4.57M 46.48% | 7.70M 68.37% | 4.79M 37.76% | 4.79M 0% | 9.29M 93.82% | 9.77M 5.18% | |
research and development expenses | 10.60M - | 20.32M 91.64% | 12.90M 36.53% | 25.81M 100.12% | 12.48M 51.66% | 23.68M 89.79% | 13.35M 43.61% | 25.16M 88.44% | 15.73M 37.50% | 28.41M 80.64% | 12.28M 56.76% | 24.57M 100% | 14.54M 40.83% | 14.54M 0% | 22.91M 57.56% | 20.52M 10.42% | |
other expenses | -14.54M - | -14.54M 0% | -20.52M - | ||||||||||||||
cost and expenses | 15.40M - | 35.90M 133.16% | 19.70M 45.12% | 33.69M 71.02% | 19.61M 41.80% | 37.10M 89.18% | 38.34M 3.36% | 37.11M 3.21% | 19.56M 47.29% | 40.60M 107.55% | 16.31M 59.82% | 33.71M 106.66% | 19.33M 42.67% | 19.33M 0% | -33.04M 270.93% | 30.29M 191.67% | |
operating expenses | 4.79M - | 33.71M 603.31% | 6.80M 79.82% | 31.32M 360.31% | 7.13M 77.23% | 35.05M 391.61% | 24.99M 28.71% | 34.73M 38.98% | 3.83M 88.96% | 36.95M 863.80% | 4.03M 89.10% | 32.27M 700.87% | 4.79M 85.15% | 4.79M 0% | 32.19M 571.93% | 9.77M 69.66% | |
interest expense | 94K - | 324K - | 1.51M - | 300K - | 3.67M 1,125% | 229K 93.77% | |||||||||||
ebitda | -9.45M - | -24.39M 157.98% | -12.16M 50.13% | -28.52M 134.54% | 4.99M 117.51% | 6.22M 24.48% | -11.01M 277.01% | -26.42M 140.09% | 1.41M 105.33% | -1.61M 214.12% | -5.20M 223.26% | -15.71M 202.23% | -12.78M 18.64% | -12.78M 0% | -23.05M 80.36% | -25.06M 8.71% | |
operating income | -10.27M - | -26.58M 158.81% | -13.64M 48.67% | -30.90M 126.50% | 4.25M 113.74% | 4.17M 1.68% | -12.46M 398.43% | -28.80M 131.18% | -199.50K 99.31% | -5.25M 2,533.08% | -6.13M 16.79% | -17.16M 179.64% | -13.16M 23.31% | -13.16M 0% | -28.71M 118.23% | -25.43M 11.44% | |
depreciation and amortization | 816.50K - | 2.19M 168.46% | 1.48M 32.41% | 2.38M 60.45% | 748K 68.53% | 2.04M 172.99% | 1.45M 28.77% | 2.38M 63.77% | 1.61M 32.47% | 3.65M 126.61% | 937K 74.29% | 1.45M 54.32% | 375K 74.07% | 375K 0% | 848K 126.13% | 366K 56.84% | |
total other income expenses net | 1.53M - | -2.07M 235.09% | -361K 82.59% | 1.48M 511.08% | -1.06M 171.33% | -2.07M 95.47% | -19.71M 852.85% | -39.31M 99.39% | 1.06M 102.69% | 2.12M 100% | 1.49M 29.57% | 2.99M 100.74% | 774.50K 74.12% | 774.50K 0% | 566K 26.92% | 4.08M 621.38% | |
income before tax | -8.73M - | -28.65M 228.01% | -14.00M 51.12% | -29.42M 110.06% | 3.19M 110.84% | 2.11M 33.94% | -32.17M 1,627.73% | -68.11M 111.70% | 859K 101.26% | -3.14M 465.08% | -4.64M 48.09% | -14.16M 204.97% | -12.38M 12.58% | -12.38M 0% | -28.14M 127.31% | -21.34M 24.16% | |
income tax expense | -4.93M - | -7.66M - | -4.27M - | -3.77M - | -4.85M - | -4.88M - | -4.05M - | -3.44M 15.11% | |||||||||
net income | -8.73M - | -23.72M 171.54% | -14.00M 40.96% | -29.09M 107.73% | 3.19M 110.96% | 6.30M 97.71% | -32.17M 610.46% | -64.41M 100.18% | 859K 101.33% | 1.72M 100% | -4.64M 370.31% | -9.29M 100% | -12.38M 33.31% | -12.38M 0% | -24.71M 99.54% | -21.34M 13.61% | |
weighted average shs out | 79.00M - | 79.00M 0.00% | 80.09M 1.38% | 79.54M 0.68% | 79.75M 0.27% | 79.74M 0.02% | 79.11M 0.79% | 79.11M 0% | 83.78M 5.91% | 80.32M 4.13% | 80.59M 0.33% | 79.88M - | 79.88M 0% | 81.25M 1.70% | 85.38M 5.08% | ||
weighted average shs out dil | 79.00M - | 79.00M 0% | 80.09M 1.38% | 79.54M 0.68% | 81.89M 2.95% | 81.87M 0.02% | 79.53M 2.86% | 80.19M 0.84% | 85.90M 7.12% | 83.78M 2.47% | 80.59M 3.81% | 80.87M - | 80.87M 0% | 81.25M 0.46% | 86.94M 7.00% | ||
eps | -0.11 - | -0.30 172.73% | -0.17 43.33% | -0.37 117.65% | 0.04 110.81% | 0.08 97.50% | -0.41 618.99% | -0.80 95.12% | 0.01 101.25% | 0.02 114.00% | -0.06 369.16% | -0.12 108.33% | -0.15 25% | -0.15 0% | -0.30 100% | -0.25 16.67% | |
epsdiluted | -0.11 - | -0.30 172.73% | -0.17 43.33% | -0.37 117.65% | 0.04 110.51% | 0.08 97.94% | -0.40 619.48% | -0.80 100% | 0.01 101.29% | 0.02 99.03% | -0.06 380.98% | -0.12 108.33% | -0.15 25% | -0.15 0% | -0.30 100% | -0.25 16.67% |
All numbers in USD (except ratios and percentages)